Want to join the conversation?
Biopharmaceutical company $CELG said it has elected Mark Alles, most recently President and COO, and Jacqualyn Fouse, most recently President of Hematology and Oncology, to its BoD. Effective March 1, Alles will become CEO, with Bob Hugin assuming the Executive Chairman role, and Fouse will become President and COO.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?